Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of Canagliflozin on Bone Metabolism in Healthy Volunteers
NCT02404870Phase 1Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Sep 2014
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Canagliflozin Sequence with Placebo Sequence (2 arms). Primary endpoint: Area Under the Curve of Fibroblast Growth Factor 23. Started Sep 2014; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02404870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02404870.